Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Zeitschrift Fur Rheumatologie|April 26, 2023
[Mechanisms of immunological tolerance and their dysregulation in rheumatic diseases]Florian Meier, Harald BurkhardtClinical and Experimental Rheumatology|October 17, 2015
Anti-TNFα-therapy as an evidence-based treatment option for different clinical manifestations of psoriatic arthritisMichaela Köhm, Harald Burkhardt, Frank BehrensDeutsche Medizinische Wochenschrift (1946)|June 4, 2020
[Treatment strategies in psoriatic arthritis]Michaela Köhm, Harald Burkhardt, Frank BehrensEuropean Journal of Immunology|April 17, 2014
Autoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritisRikard Holmdahl, Vivianne Malmström, Harald BurkhardtCurrent Opinion in Rheumatology|March 24, 2011
Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknessesFrank Behrens, Michaela Koehm, Harald BurkhardtJournal of Cellular and Molecular Medicine|September 9, 2008
ADAM15 modulates outside-in signalling in chondrocyte-matrix interactionsBeate B Böhm, Andrea Schirner, Harald BurkhardtCells|July 10, 2020
Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory DiseasesBettina Sehnert, Harald Burkhardt, Stefan Dübel, et al.Methods in Molecular Biology (Clifton, N.J.)|March 5, 2015
The "sneaking-ligand" approach: cell-type specific inhibition of the classical NF-κB pathwayBettina Sehnert, Harald Burkhardt, Stefan Dübel, et al.The Journal of Biological Chemistry|May 1, 2012
ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditionsDorothee Fried, Beate B Böhm, Kristin Krause, et al.European Journal of Immunology|October 1, 2008
Collagen type II is recognized by a pathogenic antibody through germline encoded structuresUlrika Böiers, Harald Lanig, Bettina Sehnert, et al.Pageof 10